المؤلفون: Thomas E. Lad, Luis Baez-Diaz, Alexander H.G. Paterson, Stewart J. Anderson, Melanie Finnigan, Joël Jean Mairet, Adam Brufsky, André Robidoux, Roger R. Gomis, Louis Fehrenbacher, Norman Wolmark, Miguel Sampayo, Juan Carlos Tercero, Eleftherios P. Mamounas, Peter C. Lucas, Antonio C. Wolff, Karen M. King

المصدر: JNCI Cancer Spectrum

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Hazard ratio, medicine.disease, Placebo, Primary tumor, Confidence interval, Article, Breast cancer, Zoledronic acid, Internal medicine, medicine, Stage (cooking), business, AcademicSubjects/MED00010, Adjuvant, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::98fdfe0dbb535a4cd2f71a8804043870
http://europepmc.org/articles/PMC8346694

المؤلفون: Walter M Gregory, Roger R. Gomis, J Torres-Martin, Joël Jean-Mairet, Juan-Carlos Tercero, Robert E. Coleman

المصدر: Cancer Research. 79:P1-17

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, Proportional hazards model, Cancer, Transcription Factor Maf, medicine.disease, Primary tumor, Breast cancer, Zoledronic acid, Internal medicine, medicine, Adjuvant therapy, Biomarker (medicine), business, medicine.drug

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::013dcf1188dd81c150049b6055cb27d0
https://doi.org/10.1158/1538-7445.sabcs18-p1-17-01

المؤلفون: Joan Albanell, Joël Jean-Mairet, H Marshall, Federico Rojo, Roger R. Gomis, Juan-Carlos Tercero, David Cameron, Andrew J. Hall, Richard Bell, Robert E. Coleman

المصدر: Cancer Research. 77:P1-09

مصطلحات موضوعية: Oncology, Cancer Research, medicine.medical_specialty, business.industry, medicine.medical_treatment, Disease, Zoledronic acid, Internal medicine, Gene duplication, Medicine, business, Adjuvant, medicine.drug, Early breast cancer

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_________::58c0b084b7773e4a1c6996c120b9915a
https://doi.org/10.1158/1538-7445.sabcs16-p1-09-01

المؤلفون: David Cameron, Roger R. Gomis, Helen Marshall, R De Boer, José Luís Passos-Coelho, Diana Ritchie, Peter Barrett-Lee, Johnathan Joffe, Walter M Gregory, M. Gil, A. Bowman, Gianfilippo Bertelli, Juan-Carlos Tercero, Joël Jean-Mairet, Robert E. Coleman, Janet E. Brown, Victoria Liversedge, M. Keane, D. Dodwell, Michelle Collinson, S. O'Reilly, Caroline Wilson, Richard Bell

المصدر: Journal of Bone Oncology
Journal of Bone Oncology, Vol 13, Iss, Pp 123-135 (2018)
Dipòsit Digital de la UB
Universidad de Barcelona
Coleman, R, Collinson, M, Gregory, W, Marshall, H, Bell, R, Dodwell, D, Keane, M, Gil, M, Barrett-lee, P, Ritchie, D, Bowman, A, Liversedge, V, De Boer, R, Passos-coelho, J, O'reilly, S, Bertelli, G, Joffe, J, Brown, J, Wilson, C, Tercero, J, Jean-mairet, J, Gomis, R & Cameron, D 2018, ' Benefits and risks of adjuvant treatment with zoledronic acid in stage II/III breast cancer. 10 years follow-up of the AZURE randomized clinical trial (BIG 01/04). ', Journal of Bone Oncology . https://doi.org/10.1016/j.jbo.2018.09.008

مصطلحات موضوعية: 0301 basic medicine, Oncology, medicine.medical_specialty, lcsh:Diseases of the musculoskeletal system, medicine.medical_treatment, Stage ii, lcsh:RC254-282, law.invention, Càncer de mama, 03 medical and health sciences, 0302 clinical medicine, Breast cancer, Randomized controlled trial, law, Internal medicine, medicine, Risks and benefits, Zoledronic acid, Early breast cancer, Postmenopausal women, business.industry, AZURE, Adjuvant treatment, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, respiratory tract diseases, 030104 developmental biology, Malalties dels ossos, 030220 oncology & carcinogenesis, lcsh:RC925-935, business, Adjuvant, Bone diseases, medicine.drug, Research Article

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::129e6af06cfa59216798684a5da7c592
https://orca.cardiff.ac.uk/id/eprint/123248/1/1-s2.0-S2212137418302628-main.pdf

المؤلفون: David Cameron, David Dodwell, Joël Jean-Mairet, Juan-Carlos Tercero, Robert E. Coleman, Andrew J. Hall, Richard Bell, Roger R. Gomis, Walter M Gregory, Andrew M. Hanby, Joan Albanell, Federico Rojo, Helen Marshall

المصدر: Coleman, R, Hall, A, Albanell, J, Hanby, A, Bell, R, Cameron, D, Dodwell, D, Marshall, H, Jean-mairet, J, Tercero, J, Rojo, F, Gregory, W & Gomis, R R 2017, ' Effect of MAF amplification on treatment outcomes with adjuvant zoledronic acid in early breast cancer: a secondary analysis of the international, open-label, randomised, controlled, phase 3 AZURE (BIG 01/04) trial ', The Lancet Oncology . https://doi.org/10.1016/S1470-2045(17)30603-4

مصطلحات موضوعية: 0301 basic medicine, Oncology, Kaplan-Meier Estimate, Zoledronic Acid, law.invention, 0302 clinical medicine, Randomized controlled trial, law, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Prospective Studies, Prospective cohort study, Mastectomy, Diphosphonates, Hazard ratio, Imidazoles, Middle Aged, Treatment Outcome, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Proto-Oncogene Proteins c-maf, Female, medicine.drug, Adult, medicine.medical_specialty, Maximum Tolerated Dose, Breast Neoplasms, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Breast cancer, Internal medicine, medicine, Humans, Neoplasm Invasiveness, Survival analysis, Aged, Neoplasm Staging, Proportional Hazards Models, Intention-to-treat analysis, Dose-Response Relationship, Drug, business.industry, medicine.disease, Survival Analysis, Surgery, 030104 developmental biology, Zoledronic acid, business, Follow-Up Studies

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::170965441a5150ba4f66647b9435a58b
https://pubmed.ncbi.nlm.nih.gov/29037985

المؤلفون: Jelena Urosevic, Monica Morales, Xabier García-Albéniz, Marc Guiu, Joël Jean-Mairet, Sylwia Gawrzak, Anna Arnal-Estapé, Robert E. Coleman, Lara Nonell, Aleix Prat, Ana Rovira, Roger R. Gomis, Anna Bellmunt, Federico Rojo, Milica Pavlovic, Evarist Planet, Maria Tarragona, Ana Lluch, Joan Albanell

المصدر: JNCI Journal of the National Cancer Institute
Recercat. Dipósit de la Recerca de Catalunya
instname

مصطلحات موضوعية: Mama -- Càncer -- Aspectes genètics, Cancer Research, Pathology, medicine.medical_specialty, DNA Copy Number Variations, Bone Neoplasms, Breast Neoplasms, Article, Mice, Breast cancer, Downregulation and upregulation, Predictive Value of Tests, Cell Line, Tumor, Biomarkers, Tumor, Odds Ratio, medicine, Animals, Humans, In Situ Hybridization, Fluorescence, Proportional Hazards Models, Early breast cancer, Regulation of gene expression, Mice, Inbred BALB C, Oncogene, business.industry, Incidence, Bone metastasis, Prognosis, medicine.disease, Immunohistochemistry, Up-Regulation, Gene Expression Regulation, Neoplastic, Oncology, Proto-Oncogene Proteins c-maf, Cancer research, Heterografts, Female, business, Ossos -- Càncer

وصف الملف: application/pdf

URL الوصول: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::9bf60944817f47c2402ca57dd6216ae3
http://hdl.handle.net/10230/25715